Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$38.62 - $72.18 $11,586 - $21,654
-300 Reduced 5.26%
5,400 $338,000
Q3 2023

Nov 14, 2023

SELL
$45.39 - $59.0 $1.2 Million - $1.56 Million
-26,500 Reduced 82.3%
5,700 $258,000
Q2 2023

Aug 14, 2023

BUY
$43.47 - $67.77 $508,599 - $792,909
11,700 Added 57.07%
32,200 $1.81 Million
Q1 2023

May 15, 2023

SELL
$41.0 - $56.12 $451,000 - $617,320
-11,000 Reduced 34.92%
20,500 $927,000
Q4 2022

Feb 14, 2023

SELL
$39.19 - $65.67 $1.89 Million - $3.17 Million
-48,200 Reduced 60.48%
31,500 $1.28 Million
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $806,520 - $1.11 Million
-13,200 Reduced 14.21%
79,700 $5.21 Million
Q2 2022

Aug 15, 2022

BUY
$43.23 - $73.83 $3.98 Million - $6.8 Million
92,100 Added 11512.5%
92,900 $5.65 Million
Q1 2022

May 16, 2022

SELL
$53.19 - $79.24 $9.1 Million - $13.6 Million
-171,000 Reduced 99.53%
800 $50,000
Q4 2021

Feb 14, 2022

BUY
$70.09 - $111.29 $11.4 Million - $18.2 Million
163,300 Added 1921.18%
171,800 $13 Million
Q3 2021

Nov 15, 2021

SELL
$110.2 - $156.64 $2.76 Million - $3.92 Million
-25,000 Reduced 74.63%
8,500 $951,000
Q2 2021

Aug 16, 2021

BUY
$100.84 - $161.89 $3.38 Million - $5.42 Million
33,500 New
33,500 $5.42 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.87B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.